PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis

Brain Research

Volumn 1376, Issue , 2011, Pages 101-112

  Kanakasabai, Saravanan ^a   Walline, Crystal C ^a   Chakraborty, Sharmistha ^a   Bright, John J ^a,b  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EAE MS; IL 12 family cytokine; Inflammation; PPAR; Th1 Th17 response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMISSION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; BRAIN; CELL SEPARATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; TH1 CELLS; TH17 CELLS;

MUS;

EID: 79851512548     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.12.059     Document Type: Article

References (48)

1. Y. Azuma, M. Shinohara, P.L. Wang, and K. Ohura 15-Deoxy-delta(12, 14)-prostaglandin J(2) inhibits IL-10 and IL-12 production by macrophages Biochem. Biophys. Res. Commun. 283 2001 344 346 (Pubitemid 32924695)
2. S. Basu-Modak, O. Braissant, P. Escher, B. Desvergne, P. Honegger, and W. Wahli Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures J. Biol. Chem. 274 1999 35881 35888 (Pubitemid 129512894)
3. B. Becher, B.G. Durell, and R.J. Noelle Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 J. Clin. Invest. 110 2002 493 497 (Pubitemid 34919703)
4. W.S. Begolka, C.L. Vanderlugt, S.M. Rahbe, and S.D. Miller Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis J. Immunol. 161 1998 4437 4446 (Pubitemid 28469031)
5. D. Centonze, L. Muzio, S. Rossi, F. Cavasinni, V. De Chiara, A. Bergami, A. Musella, M. D'Amelio, V. Cavallucci, A. Martorana, A. Bergamaschi, M.T. Cencioni, A. Diamantini, E. Butti, G. Comi, G. Bernardi, F. Cecconi, L. Battistini, R. Furlan, and G. Martino Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis J. Neurosci. 29 2009 3442 3452
6. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748 (Pubitemid 36227625)
7. G. Dean How many people in the world have multiple sclerosis? Neuroepidemiology 13 1994 1 7 (Pubitemid 24107445)
8. A. Diab, C. Deng, J.D. Smith, R.Z. Hussain, B. Phanavanh, A.E. Lovett-Racke, P.D. Drew, and M.K. Racke Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12, 14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis J. Immunol. 168 2002 2508 2515 (Pubitemid 34171857)
9. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors Cell 68 1992 879 887
10. D.L. Feinstein, E. Galea, V. Gavrilyuk, C.F. Brosnan, C.C. Whitacre, L. Dumitrescu-Ozimek, G.E. Landreth, H.A. Pershadsingh, G. Weinberg, and M.T. Heneka Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis Ann. Neurol. 51 2002 694 702 (Pubitemid 34568847)
11. A.R. Gocke, P.D. Cravens, L.H. Ben, R.Z. Hussain, S.C. Northrop, M.K. Racke, and A.E. Lovett-Racke T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity J. Immunol. 178 2007 1341 1348 (Pubitemid 46154603)
12. T.L. Graham, C. Mookherjee, K.E. Suckling, C.N. Palmer, and L. Patel The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice Atherosclerosis 181 2005 29 37 (Pubitemid 40804690)
13. J. Granneman, R. Skoff, and X. Yang Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes J. Neurosci. Res. 51 1998 563 573 (Pubitemid 28115057)
14. R. Hontecillas, and J. Bassaganya-Riera Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis J. Immunol. 178 2007 2940 2949 (Pubitemid 46333173)
15. M.A. Jakobsen, R.K. Petersen, K. Kristiansen, M. Lange, and S.T. Lillevang Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands Scand. J. Immunol. 63 2006 330 337
16. S. Kanakasabai, W. Chearwae, C.C. Walline, W. Iams, S.M. Adams, and J.J. Bright Peroxisome proliferator-activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis Immunology 130 2010 572 588
17. K. Kang, S.M. Reilly, V. Karabacak, M.R. Gangl, K. Fitzgerald, B. Hatano, and C.H. Lee Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity Cell Metab. 7 2008 485 495 (Pubitemid 351729204)
18. M.K. Kennedy, D.S. Torrance, K.S. Picha, and K.M. Mohler Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery J. Immunol. 149 1992 2496 2505
19. S.A. Kliewer, H.E. Xu, M.H. Lambert, and T.M. Willson Peroxisome proliferator-activated receptors: from genes to physiology Recent Prog. Horm. Res. 56 2001 239 263
20. A.P. Kohm, P.A. Carpentier, H.A. Anger, and S.D. Miller Cutting edge: CD4 + CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis J. Immunol. 169 2002 4712 4716 (Pubitemid 35217131)
21. Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis J. Immunol. 177 2006 566 573 (Pubitemid 43939170)
22. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J. Exp. Med. 201 2005 233 240 (Pubitemid 40189432)
23. A.E. Lovett-Racke, R.Z. Hussain, S. Northrop, J. Choy, A. Rocchini, L. Matthes, J.A. Chavis, A. Diab, P.D. Drew, and M.K. Racke Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease J. Immunol. 172 2004 5790 5798 (Pubitemid 38542085)
24. C. Lucchinetti, W. Bruck, and J. Noseworthy Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment Curr. Opin. Neurol. 14 2001 259 269 (Pubitemid 32510588)
25. C. Mo, W. Chearwae, J.T. O'Malley, S.M. Adams, S. Kanakasabai, C.C. Walline, G.L. Stritesky, S.R. Good, N.B. Perumal, M.H. Kaplan, and J.J. Bright Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis J. Immunol. 181 2008 5681 5690
26. E. Montero, G. Nussbaum, J.F. Kaye, R. Perez, A. Lage, A. Ben-Nun, and I.R. Cohen Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies J. Autoimmun. 23 2004 1 7 (Pubitemid 38953787)
27. L. Mukundan, J.I. Odegaard, C.R. Morel, J.E. Heredia, J.W. Mwangi, R.R. Ricardo-Gonzalez, Y.P. Goh, A.R. Eagle, S.E. Dunn, J.U. Awakuni, K.D. Nguyen, L. Steinman, S.A. Michie, and A. Chawla PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance Nat. Med. 15 2009 1266 1272
28. C. Natarajan, and J.J. Bright Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation Genes Immun. 3 2002 59 70 (Pubitemid 38961111)
29. C. Natarajan, G. Muthian, Y. Barak, R.M. Evans, and J.J. Bright Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis J. Immunol. 171 2003 5743 5750 (Pubitemid 37467189)
30. M. Niino, K. Iwabuchi, S. Kikuchi, M. Ato, T. Morohashi, A. Ogata, K. Tashiro, and K. Onoe Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma J. Neuroimmunol. 116 2001 40 48 (Pubitemid 32322638)
31. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N. Engl. J. Med. 343 2000 938 952
32. K.C. O'Connor, A. Bar-Or, and D.A. Hafler The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis J. Clin. Immunol. 21 2001 81 92 (Pubitemid 32328759)
33. J.M. Peters, S.S. Lee, W. Li, J.M. Ward, O. Gavrilova, C. Everett, M.L. Reitman, L.D. Hudson, and F.J. Gonzalez Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta) Mol. Cell. Biol. 20 2000 5119 5128 (Pubitemid 30431565)
34. J.M. Peters, H.E. Hollingshead, and F.J. Gonzalez Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease Clin. Sci. (Lond.) 115 2008 107 127
35. P.E. Polak, S. Kalinin, C. Dello Russo, V. Gavrilyuk, A. Sharp, J.M. Peters, J. Richardson, T.M. Willson, G. Weinberg, and D.L. Feinstein Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis J. Neuroimmunol. 168 2005 65 75 (Pubitemid 41396404)
36. C.M. Poser The pathogenesis of multiple sclerosis: a commentary Clin. Neurol. Neurosurg. 102 2000 191 194 (Pubitemid 32012612)
37. H.P. Raikwar, G. Muthian, J. Rajasingh, C. Johnson, and J.J. Bright PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis J. Neuroimmunol. 167 2005 99 107 (Pubitemid 41242292)
38. I. Saluja, J.G. Granneman, and R.P. Skoff PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture Glia 33 2001 191 204 (Pubitemid 32219128)
39. L.J. Saubermann, A. Nakajima, K. Wada, S. Zhao, Y. Terauchi, T. Kadowaki, H. Aburatani, N. Matsuhashi, R. Nagai, and R.S. Blumberg Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis Inflamm. Bowel Dis. 8 2002 330 339
40. M.V. Simonini, P.E. Polak, A.I. Boullerne, J.M. Peters, J.C. Richardson, and D.L. Feinstein Regulation of oligodendrocyte progenitor cell maturation by PPARdelta: effects on bone morphogenetic proteins ASN Neuro. 2009 10.1042/AN2009003
41. L.A. Stephens, D. Gray, and S.M. Anderton CD4 + CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity Proc. Natl Acad. Sci. USA 102 2005 17418 17423 (Pubitemid 41740881)
42. Y. Takata, J. Liu, F. Yin, A.R. Collins, C.J. Lyon, C.H. Lee, A.R. Atkins, M. Downes, G.D. Barish, R.M. Evans, W.A. Hsueh, and R.K. Tangirala PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis Proc. Natl Acad. Sci. USA 105 2008 4277 4282 (Pubitemid 351754371)
43. P.W. Thompson, A.I. Bayliffe, A.P. Warren, and J.R. Lamb Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+ T cells Cytokine 39 2007 184 191 (Pubitemid 47610737)
44. C.C. Whitacre, S.C. Reingold, and P.A. O'Looney A gender gap in autoimmunity Science 283 1999 1277 1278 (Pubitemid 129507205)
45. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550 (Pubitemid 30127149)
46. D.M. Wingerchuk, C.F. Lucchinetti, and J.H. Noseworthy Multiple sclerosis: current pathophysiological concepts Lab Invest. 81 2001 263 281 (Pubitemid 32245059)
47. J.W. Woods, M. Tanen, D.J. Figueroa, C. Biswas, E. Zycband, D.E. Moller, C.P. Austin, and J.P. Berger Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons Brain Res. 975 2003 10 21 (Pubitemid 36588548)
48. J. Xu, and P.D. Drew Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia J. Immunol. 178 2007 1904 1913 (Pubitemid 46154663)